What are the best treatments for Macular Degeneration?

Treatments for Macular Degeneration depend heavily on whether the condition is the "dry" (atrophic) or "wet" (neovascular) form. While there is currently no cure for dry Macular Degeneration, wet Macular Degeneration is primarily treated with anti-VEGF injections to prevent vision loss, often resulting in stabilized or improved vision for many patients.

What are the primary medical treatments for Macular Degeneration?

For wet Macular Degeneration, the gold standard is the regular injection of anti-VEGF (vascular endothelial growth factor) medications into the eye. These drugs block the protein that causes abnormal blood vessel growth. For dry Macular Degeneration, the focus is on slowing progression through nutritional supplementation based on the AREDS2 formula, which includes high doses of vitamins C and E, zinc, copper, lutein, and zeaxanthin.

What medications are commonly used?

Commonly prescribed anti-VEGF agents for wet Macular Degeneration include:

• Aflibercept (Eylea)


• Ranibizumab (Lucentis)


• Bevacizumab (Avastin)


• Faricimab-svoa (Vabysmo)

What non-pharmacological and surgical options exist?

Beyond medications, patients may benefit from low-vision rehabilitation, which includes occupational therapy to maximize remaining functional vision. While laser surgery was common historically, it is now used sparingly. Ongoing clinical trials are exploring gene therapies and stem cell treatments for advanced geographic atrophy, the late stage of dry Macular Degeneration.

Which specialists should be on my care team?

Managing Macular Degeneration requires a multidisciplinary approach. Your care team should ideally include:

• Retina Specialist: An ophthalmologist with fellowship training in retinal diseases to manage injections.


• Low Vision Specialist: An optometrist or ophthalmologist who helps with adaptive devices.


• Occupational Therapist: To assist with daily living adjustments.


• Genetic Counselor: To assess hereditary risk factors if family history is present.

Next steps

• Schedule a comprehensive dilated eye exam with a retina specialist to determine your specific disease subtype.


• Inquire about whether the AREDS2 supplement formula is appropriate for your stage of disease.


• Connect with the 9 community members on DiseaseMaps.org to share experiences and coping strategies.


• Monitor your vision daily using an Amsler grid and report any sudden changes to your physician immediately.

Medical disclaimer: Treatment plans must be personalized by your medical team; never adjust medications or supplement intake without professional clinical guidance.

References

• National Eye Institute (NEI): Age-Related Macular Degeneration (AMD) Fact Sheet.


• NIH Genetic and Rare Diseases (GARD) Information Center.


• American Academy of Ophthalmology (AAO) Clinical Practice Guidelines.


• Macular Degeneration Association (MDA).